Overall, we strive to advance scientific knowledge by highlighting the understudied role of SDHA and LRPPRC in ovarian cancer and their potential utility as biomarkers of high-OXPHOS tumors to guide personalized cancer therapy. This evidence concerns the gene LRPPRC and ovarian carcinoma.